Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

170
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
170
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

291
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
291
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Artificial Intelligence-Based Localization of Small Bowel Anatomic Transition Zones in Crohn's Disease Using Capsule Endoscopy.

Endoscopy international open·2026
Same author

Artificial Intelligence Versus Conventional Scoring for Assessing Small Bowel Capsule Endoscopy Cleanliness in Crohn's Disease.

United European gastroenterology journal·2026
Same author

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Clinics and research in hepatology and gastroenterology·2026
Same author

Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Impact of Endometriosis on the Progression of Inflammatory Bowel Diseases: A Multicenter Retrospective Study.

Clinical and translational gastroenterology·2025
Same author

Clinical Trial: Simplified Bowel Preparation for Small Bowel Capsule Endoscopy in Crohn's Disease.

Alimentary pharmacology & therapeutics·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jul 19, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.3K

La colitis ulcerosa

Catherine Le Berre1, Sailish Honap2, Laurent Peyrin-Biroulet3

  • 1Institut des Maladies de l'Appareil Digestif, Hépato-Gastro-Entérologie et Assistance Nutritionnelle, Inserm CIC 1413, Inserm UMR 1235, Nantes Université, CHU Nantes, Nantes, France.

Lancet (London, England)
|August 12, 2023
PubMed
Resumen

La colitis ulcerosa, una inflamación intestinal crónica, afecta a millones de personas en todo el mundo. Los nuevos tratamientos tienen como objetivo la remisión y la curación endoscópica, pero algunos pacientes aún necesitan cirugía, lo que pone de relieve la necesidad de la medicina de precisión.

Más Videos Relacionados

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:21

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

182
Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

1.0K

Videos de Experimentos Relacionados

Last Updated: Jul 19, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.3K
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:21

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

182
Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

1.0K

Área de la Ciencia:

  • Gastroenterología
  • Inmunología
  • Médico interno

Sus antecedentes:

  • La colitis ulcerosa (UC) es una enfermedad inflamatoria intestinal crónica que afecta al colon, con una prevalencia global creciente.
  • La patogénesis de la UC implica predisposición genética, factores ambientales, disfunción de la barrera intestinal, alteraciones de la microbiota y desregulación inmune.
  • El diagnóstico se basa en evaluaciones clínicas, biológicas, endoscópicas e histológicas.

Objetivo del estudio:

  • Describir la comprensión y el tratamiento actuales de la colitis ulcerosa.
  • Revisar las estrategias terapéuticas para inducir y mantener la remisión en UC.
  • Explorar las direcciones futuras en el tratamiento de la UC, haciendo hincapié en la precisión y la medicina personalizada.

Principales métodos:

  • Revisión de la literatura médica actual sobre la colitis ulcerosa.
  • Análisis de los criterios de diagnóstico y las modalidades de tratamiento de la UC.
  • Discusión de objetivos y enfoques terapéuticos emergentes.

Principales resultados:

  • Los tratamientos actuales incluyen medicamentos con ácido 5-aminosalicílico, corticosteroides, tiopurinas, biológicos y moléculas pequeñas para el tratamiento de la UC.
  • A pesar de los avances terapéuticos, el 10-20% de los pacientes con UC requieren proctocolectomía debido a la enfermedad refractaria.
  • La expansión de las opciones terapéuticas ofrece esperanza, pero siguen existiendo desafíos para lograr una remisión a largo plazo y prevenir la discapacidad.

Conclusiones:

  • El tratamiento eficaz de la colitis ulcerosa requiere inducir una respuesta clínica rápida y mantener la remisión a largo plazo con biomarcadores normalizados y curación endoscópica.
  • La combinación de terapias, medicina de precisión y enfoques personalizados puede superar las limitaciones actuales del tratamiento en la colitis ulcerosa.
  • La investigación continua sobre la patogénesis de la UC y las nuevas estrategias terapéuticas es crucial para mejorar los resultados de los pacientes.